Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study

NCT06376058 is registered in ClinicalTrials.gov with Aretaieion University Hospital as lead sponsor.

NCT NCT06376058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study
Lead sponsor
Aretaieion University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 10, 2024
Completion date
January 10, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section, local anesthetic